These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7413648)

  • 1. The pharmacotherapy of depression in the elderly: pharmacokinetic considerations.
    Friedel RO
    Proc Annu Meet Am Psychopathol Assoc; 1980; 69():157-65. PubMed ID: 7413648
    [No Abstract]   [Full Text] [Related]  

  • 2. Doxepin inhibits CYP2D6 activity in vivo.
    Szewczuk-Bogusławska M; Kiejna A; Beszłej JA; Orzechowska-Juzwenko K; Milejski P
    Pol J Pharmacol; 2004; 56(4):491-4. PubMed ID: 15520506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical importance of doxepin antidepressant plasma levels.
    Green DO
    J Clin Psychiatry; 1978 May; 39(5):481-2. PubMed ID: 641025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Symptoms of depressive state in otolaryngology].
    Ye F; Li X; Lu Q
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Apr; 32(2):121-3. PubMed ID: 10743145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective pharmacokinetics of doxepin isomers.
    Midha KK; Hubbard JW; McKay G; Hawes EM; Korchinski ED; Gurnsey T; Cooper JK; Schwede R
    Eur J Clin Pharmacol; 1992; 42(5):539-44. PubMed ID: 1607001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxepin plasma levels and therapeutic response in depression: preliminary findings.
    Ward NG; Bloom VL; Wilson L; Raskind M; Raisys VA
    J Clin Psychopharmacol; 1982 Apr; 2(2):126-8. PubMed ID: 7076877
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic evaluation of two doxepin products.
    Wecker MT; Woodworth JR; Amsel LP; Hinsvark ON; Rotenberg KS
    Clin Ther; 1986; 8(3):342-7. PubMed ID: 3719617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of depressed geriatric patients.
    Ban TA
    Am J Psychother; 1978 Jan; 32(1):93-104. PubMed ID: 655309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of tricyclic antidepressants in plasma, heart and skeletal muscle after their intravenous infusion to anaesthetized rabbits.
    Elonen E; Linnoila M; Lukkari I; Mattila MJ
    Acta Pharmacol Toxicol (Copenh); 1975 Oct; 37(4):274-81. PubMed ID: 1242609
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression, tricyclic antidepressants and clinical laboratories.
    Sannella JJ
    J Tenn Med Assoc; 1979 Feb; 72(2):120, 122. PubMed ID: 431066
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of doxepin in the treatment of depression syndromes].
    Grzejdziak N; Wierzbicki T
    Psychiatr Pol; 1974; 8(4):433-4. PubMed ID: 4411427
    [No Abstract]   [Full Text] [Related]  

  • 14. [Depression of a developmentally retarded patient].
    Koskentausta T
    Duodecim; 1996; 112(3):223, 237. PubMed ID: 10590633
    [No Abstract]   [Full Text] [Related]  

  • 15. Weight loss and a concomitant change in plasma tricyclic levels.
    Jobson K; Burnett G; Linnoila M
    Am J Psychiatry; 1978 Feb; 135(2):237-8. PubMed ID: 623344
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing depression in outpatients.
    Gorelick DA
    N Engl J Med; 2001 Apr; 344(16):1252; author reply 1253. PubMed ID: 11314689
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of Sinequan in the treatment of different clinical forms of depression].
    Majczak A; Masiak M; Grzywa A; Górniewicz A; Komada J
    Psychiatr Pol; 1975; 9(1):51-7. PubMed ID: 1118518
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized controlled clinical trial comparing "guideline exposed" and "guideline naive" physicians in respect to dosage selection and treatment outcome with doxepin in depressive disorders.
    Linden M; Schotte K
    Pharmacopsychiatry; 2007 Mar; 40(2):77-81. PubMed ID: 17447178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor.
    Nemeroff CB
    Pharmacotherapy; 1994; 14(2):127-38. PubMed ID: 8197030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Doxepin, a new antidepressive drug for internal clinic (author's transl)].
    Lankosz J; Weselucha P
    Przegl Lek; 1974; 31(5):573-7. PubMed ID: 4848524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.